FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
KESTRA MEDICAL TECHNOLOGIES, LTD. Stock AnalysisComprehensive stock analysis for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisKMTS
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
KMTS
Home🔹Stocks🔹KESTRA MEDICAL TECHNOLOGIES, LTD.

KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS•NASDAQ

KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS•NASDAQ
Market cap
$1.40B
Sentiment

Your view on KMTS

Mkt Cap
$1.40B
Sentiment
Your view
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
KMTS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About KESTRA MEDICAL TECHNOLOGIES, LTD.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Brian Webster
Headquarters
US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Brian Webster
Headquarters
US
Description

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News